JSPR Jasper Therapeutics Inc
Company Analysis
Latest News
Jasper Therapeutics Proposes Reverse Split, Aiming to Save Nasdaq Listing
Jasper Therapeutics, Inc. scheduled a special stockholder meeting for September 30, 2026. Shareholders will vote on a proposed reverse stock split at a ratio...
🔴 Jasper Therapeutics is trading 5.16% down in pre-market as catalyst remains unclear
Jasper Therapeutics is trading at $0.65 (-5.16%) before the September 4, 2026 open, with no clear company-specific catalyst identified. - The...
🔴 Jasper Therapeutics is trading 6.23% down today as the catalyst remains unclear
Jasper Therapeutics is trading at $0.66, down 6.23%, as no clear company-specific announcement has emerged on September 3, 2026. - The company’s...
🔴 Jasper Therapeutics is trading 12.33% down today in pre-market as U.S.-Iran tensions pressured biotech shares
Jasper Therapeutics is trading 12.33% down now at $0.61 after U.S.-Iran tensions lifted oil prices and pressured biotechnology shares. - It fell 5.29% in...
🔴 Jasper Therapeutics is trading 5.29% down in after-hours trading as U.S.-Iran tensions pressure biotech shares
Jasper Therapeutics is trading at $0.66, down 5.29% after-hours on September 1, 2026, amid broad risk aversion as U.S.-Iran tensions lifted oil prices and...
🔴 Jasper Therapeutics is trading 10.68% down today as U.S.-Iran clashes fuel risk aversion
Jasper Therapeutics is trading at $0.64 (-10.68%) amid renewed U.S.-Iran clashes, rising oil prices, and broader risk aversion. - Biotech shares are under...
🔴 Jasper Therapeutics is trading 5.48% down today amid renewed U.S.-Iran clashes
Jasper Therapeutics is trading at $0.67 (-5.48%) after renewed U.S.-Iran clashes intensified global risk-off sentiment and pushed oil prices higher. - The...
🔴 Jasper Therapeutics is trading 8.63% down in pre-market as renewed U.S.-Iran clashes intensify global risk-off sentiment
Jasper Therapeutics is trading 8.63% down at $0.65 in pre-market after renewed U.S.-Iran clashes intensified global risk-off sentiment. - Reuters reported oil...
🔴 Jasper Therapeutics is trading 5.4% down today amid renewed U.S.-Iran clashes
Jasper Therapeutics is trading at $0.66 (-5.39%) amid broad risk-off trading following renewed U.S.-Iran clashes. - No new company-specific announcement or...
🔴 Jasper Therapeutics falls 5.5% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
Jasper Therapeutics Receives Nasdaq Non-Compliance Notice Over Listing Rule
Jasper Therapeutics, Inc. (JSPR) announced it received a notice from The Nasdaq Stock Market on August 21, 2026, indicating the company is not in compliance...
Jasper Therapeutics proposes reverse split, fighting to keep Nasdaq listing
Jasper Therapeutics scheduled a special stockholder meeting for September 30, 2026. Investors will vote on a proposed reverse stock split. The board seeks...
Jasper Therapeutics second quarter 2026 net loss narrows to $2.8M amid Kira acquisition and $132M financing
Jasper Therapeutics reported a net loss of $2.8 million for the second quarter 2026, a significant reduction from the $26.7 million loss in the prior-year...